Cetera Investment Advisers
ANVS icon

Cetera Investment Advisers’s Annovis Bio ANVS Stock Holding History

Cetera Investment Advisers’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,175
Closed -$133K – 3734
2024
Q1 		$133K Buy
+11,175
New +$122K ﹤0.01% 3444

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Cetera Investment Advisers's ANVS Position: Q2 2024 in Review

Cetera Investment Advisers sold out of Annovis Bio (ANVS) in Q2 2024, closing a stake of 11,175 shares — an estimated $133K sold.

Cetera Investment Advisers first reported a position in ANVS in Q1 2024 and held it in 1 quarter. The position peaked at $133K in Q1 2024. 31 funds tracked by Wall St. Rank hold ANVS as of Q2 2024.

  • Cetera Investment Advisers reported no remaining Annovis Bio position as of Q2 2024 after selling out during the quarter.
  • Cetera Investment Advisers sold 11,175 Annovis Bio shares in Q2 2024, an estimated $133K.
  • Cetera Investment Advisers first reported a position in Annovis Bio in Q1 2024 and held it in 1 quarter.
  • Cetera Investment Advisers's Annovis Bio position peaked at $133K in Q1 2024.
  • 31 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2024.

Based on Cetera Investment Advisers's 13F filing for Q2 2024, filed 22 Aug 2024.